Top Hospitals in South China: Guangdong & Hainan Overview

Why South China Is Becoming a Global Medical Destination

When international patients think of medical treatment in China, Beijing and Shanghai often come to mind first. But a quiet transformation is underway in the country’s southern provinces — Guangdong and Hainan — that is reshaping the medical tourism landscape. With a subtropical climate, lower costs, world-class hospitals, and a unique special-permit policy zone that grants access to the latest drugs and devices months or even years before they reach the rest of China, South China is emerging as a compelling alternative for patients from Canada, the UK, France, the US, the Middle East, Russia, and beyond.

In 2025, China’s key foreign-related hospitals received 1.28 million international patient visits — a 73.6% increase from three years earlier, according to the National Health Commission (source: National Health Commission 2025 Foreign-Related Medical Service Report). Guangdong alone saw a 20% year-on-year increase in foreign patient visits, with inpatient demand surging 76.05% (source: Guangdong Provincial Health Commission, March 2026). Meanwhile, Hainan’s Boao Lecheng Pilot Zone hosted 413,700 medical tourism visits in 2024, growing 36.8% year-on-year (source: Xinhua News Agency, March 2025).

This article provides a comprehensive overview of the top hospitals in Guangdong and Hainan, their international patient capabilities, and why more patients from around the world are choosing South China for their medical care.

Guangdong: A Medical Powerhouse

Guangdong Province, with a population exceeding 127 million and a GDP larger than that of most countries, is home to some of China’s finest medical institutions. The province’s capital, Guangzhou, is consistently ranked alongside Beijing and Shanghai as one of China’s top three medical hubs.

The First Affiliated Hospital, Sun Yat-sen University

Ranked 6th nationally and 1st in South China on the prestigious Fudan University China Hospital Ranking (2023), this 115-year-old institution is a comprehensive national medical center. It holds 5 national key disciplines and 30 national clinical key specialties.

In March 2025, the hospital inaugurated its new medical complex — the Joseph Lau Building — which houses the newly launched Jianhua International Medical Center. Donated by Chen Jianhua, chairman of Hengli Group, this center consolidates the hospital’s 36 national clinical key specialties into a dedicated international patient facility. The same month, the hospital performed the world’s first “external liver” treatment for a patient with end-stage liver failure who was contraindicated for traditional transplantation (source: FAH-SYSU official announcement, March 2025).

The hospital has also established a five-year strategic partnership with Dana-Farber Cancer Institute, a Harvard Medical School-affiliated teaching hospital, to advance cancer care innovation (source: FAH-SYSU, March 2025). It is designated under the “Hong Kong-Macao Drug and Medical Device Access Policy” and was selected as one of Guangdong’s first 25 International Medical Service Pilot Hospitals in March 2026 (source: Guangdong Provincial Health Commission, March 2026).

Key specialties: Organ transplantation, nephrology, gastroenterology, cardiovascular diseases, oncology, neurology.

Nanfang Hospital, Southern Medical University

Nanfang Hospital, also known as Southern Hospital, is ranked among the A++++ tier (the highest level) in the Fudan ranking and placed 12th nationally in the 2024 Nature Index of Chinese hospitals (source: Nature Index, 2024). Its international medical services trace back to 1979 with the founding of the “Huiqiao Building” — the first dedicated foreign-patient medical facility in China, often called “China’s first international medical building.”

Today, Nanfang Hospital’s international medical network covers 92 countries and regions, having served over 260,000 international patients cumulatively (source: Southern Medical University Hospital Management Office, March 2026). It pioneered the “medical + tourism” model and established a “general practice + specialist” international service framework. The hospital was selected as one of Guangdong’s first 25 International Medical Service Pilot Hospitals in 2026.

Key specialties: Hepatobiliary surgery, nephrology, infectious diseases, hematology, organ transplantation.

Guangdong Provincial People’s Hospital

Ranked 48th nationally in the 2026 SCImago Institutions Rankings for the health sector (source: SCImago IR, 2026), this hospital’s Xiehe Advanced Medical Center was established in 1996 as the first public hospital international medical platform in China to adopt Hong Kong’s private hospital operational model. The center spans over 5,000 square meters with 54 private/semi-private rooms, offering multilingual services, multidisciplinary team (MDT) consultations, direct insurance billing, and 24/7 international transfer support. It has served patients from 151 countries and regions (source: Southern Medical University Hospital Management Office, March 2026).

The hospital was also selected as one of Guangdong’s first 25 International Medical Service Pilot Hospitals.

Key specialties: Cardiovascular diseases, cardiothoracic surgery, geriatrics, oncology.

The First Affiliated Hospital of Guangzhou Medical University

This hospital’s respiratory medicine department has been ranked No. 1 nationally for over a decade on the Fudan specialty reputation ranking. Led by the renowned Dr. Zhong Nanshan, the department is China’s undisputed leader in respiratory diseases, particularly during and after the COVID-19 pandemic. Its thoracic surgery department ranks 6th nationally (source: Fudan University China Hospital Ranking, multiple years). The hospital has been in the national top 100 for seven consecutive years.

Key specialties: Respiratory medicine, thoracic surgery, critical care medicine.

Shenzhen People’s Hospital

As Shenzhen’s first “Grade 3A” hospital (designated in 1994), this institution has been ranked among the national top 100 hospitals for three consecutive years. It holds multiple national clinical key specialties and has been at the forefront of Shenzhen’s healthcare development. The hospital benefits from Shenzhen’s unique position as a Special Economic Zone adjacent to Hong Kong, with strong cross-border medical collaboration.

Key specialties: Cardiology, neurology, oncology, reproductive medicine.

Guangdong’s 25 International Medical Service Pilot Hospitals

In March 2026, Guangdong Province officially launched its International Medical Service Pilot Program, designating 25 hospitals as pilot institutions. These hospitals operate under international standards for quality control, management, and payment — accepting out-of-pocket settlement, foreign currency, and international commercial insurance rather than China’s basic medical insurance system. Most are also designated under the “Hong Kong-Macao Drug and Medical Device Access Policy,” which has accelerated access to advanced drugs and devices in the Greater Bay Area (source: Guangdong Provincial Health Commission, March 2026; China Daily, April 2026).

Hainan: The Island of Medical Innovation

Hainan, China’s southernmost tropical island province, has undergone a remarkable healthcare transformation. Once considered a medical “lowland,” it is now a “hot land” for medical innovation, anchored by the Boao Lecheng International Medical Tourism Pilot Zone.

Boao Lecheng International Medical Tourism Pilot Zone

Established in 2013 by State Council approval, Lecheng is China’s only national-level medical tourism pilot zone. It operates under four special policies: special-permit medical care, special-permit research, special-permit operations, and special-permit international medical exchange. These policies allow the use of international innovative drugs and medical devices that are approved abroad but not yet on the Chinese market.

Key achievements as of 2025 (sources: Xinhua News Agency, March 2025; People’s Daily, November 2025):

525+ special-permit drugs and devices introduced across 40 clinical disciplines 36 medical institutions in operation, including Ruijin Hospital Hainan (affiliated with Shanghai Jiao Tong University School of Medicine) and West China Hospital 190,000+ patient uses of special-permit drugs and devices cumulatively 21 products have used Lecheng real-world data to accelerate China market registration 3 products included in China’s national medical insurance catalog through real-world evidence 413,700 medical tourism visits in 2024 (up 36.8% year-on-year) 865,300 medical tourism visits in 2025 (up 109% year-on-year) 9,344 inbound medical tourists in 2025 from 14 countries, with a 618.9% increase in H2 2025 alone International patients from Canada, Indonesia, Spain, Russia, Laos, Uzbekistan, Cuba, and more The “Lecheng + Hainan Production” model: In February 2025, a polyester collagen bone repair material imported from Switzerland became the first product to gain Chinese medical device registration through the “Lecheng R&D + Hainan Production” pathway, demonstrating how the zone can facilitate both clinical use and local manufacturing (source: China Pharmaceutical News, November 2025).

Real-world data innovation: Lecheng has built China’s first regional real-world data platform, creating a full-chain service system for data collection, ethical review, and regulatory support. This has helped accelerate the approval of innovative drugs and devices for the broader Chinese market.

Insurance partnerships: Lecheng has established strategic cooperation with AXA Hong Kong and other international insurance giants to optimize cross-border medical insurance claims and develop comprehensive health management solutions.

Hainan General Hospital

As Hainan’s flagship public hospital, Hainan General Hospital has formed a strategic alliance with the Boao Lecheng Pilot Zone. Since 2021, the hospital has led or participated in 83 special-permit drug and device projects and real-world research initiatives (source: Xinhua Hainan, May 2025). It plays a critical role in the province’s “serious diseases treated within the island” strategy, reducing the need for Hainan residents to travel to the mainland for advanced care.

Sanya People’s Hospital and Sanya Traditional Chinese Medicine Hospital

Sanya, Hainan’s tropical coastal city, has become a hub for medical tourism combining healthcare with vacation. Sanya Traditional Chinese Medicine Hospital received approximately 7,000 foreign visitors in 2024 (source: Xinhua News Agency, March 2025). The hospital has expanded TCM service trade to Spain, Brazil, Russia, and Middle Eastern countries, and has trained TCM professionals from Kazakhstan and Portugal. It also signed a charter flight agreement with Almaty Aviation for TCM wellness packages — the first Chinese medical institution to receive approval for foreign charter flights for medical tourism.

Haikou People’s Hospital

The hospital’s International Medical Department offers English-language online appointment booking, multilingual navigation, direct insurance billing, medical record translation, and 24-hour emergency channels for international patients. A Canadian patient, John, completed his entire visit — registration, consultation, and medication pickup — in just 30 minutes (source: Xinhua News Agency, March 2025).

International Patient Services: What to Expect

Hospitals in Guangdong and Hainan have developed comprehensive international patient service systems:

Source: Southern Medical University Hospital Management Office (March 2026); Zhujiang Hospital International Medical Center; Guangdong Provincial Health Commission.

Why Choose South China Over Beijing or Shanghai?

1. Climate and Recovery Environment

Guangdong and Hainan offer a subtropical to tropical climate with mild winters — a significant advantage for patients recovering from surgery or managing chronic conditions. Hainan’s air quality consistently ranks among the best in China, with the island often called “China’s Hawaii.”

2. Lower Costs

While Beijing and Shanghai are China’s most expensive cities, Guangzhou and Hainan offer comparable medical quality at 20-30% lower living and accommodation costs. According to data cited by national political advisor An Ting, China’s medical costs are approximately 1/3 to 1/2 of those in Europe, the US, and Japan (source: Life Times, March 2026). A cancer patient from the US who chose treatment in Guangzhou calculated that her total costs — including flights and accommodation — were a fraction of what she would have paid in the United States, where chemotherapy alone can cost $10,000–$20,000 per month (source: Life Times, March 2026; Sinoaid Medical Tourism Cost Comparison).

3. Boao Lecheng’s Special-Permit Drug and Device Advantage

This is perhaps the most compelling reason. Through Lecheng’s special-permit policy, patients can access innovative drugs and devices that are approved in the US, EU, or Japan but not yet available in the rest of China. For example:

• The world’s first smart cochlear implant system (Cochlear Nucleus Nexa) had its global first-batch application in Lecheng (source: China Pharmaceutical News, November 2025)

• Lenacapavir, an HIV prevention drug dosed twice yearly, was available in Lecheng just 8 working days after US FDA approval (source: same)

• Tzield, the first FDA-approved therapy to delay Type 1 diabetes onset, had its first Asian prescriptions in Lecheng (source: same)

4. Shorter Wait Times

While patients in Canada, the UK, and other countries with public healthcare systems may wait months for specialist consultations or surgeries, South China’s hospitals can typically schedule appointments within days. The UK blogger Amy, who sought treatment in China for a stomach condition, was diagnosed with a gastric ulcer on her first day — a process that would have taken months on the NHS (source: Life Times, March 2026).

5. Greater Bay Area Integration

Guangdong’s position within the Guangdong-Hong Kong-Macao Greater Bay Area means seamless connectivity with Hong Kong and Macao. International patients can fly into Hong Kong International Airport and reach Guangzhou or Shenzhen within 1-2 hours by high-speed rail or ferry.

Real Patient Story: Umar from Indonesia

Umar, a 54-year-old from Indonesia, was diagnosed with esophageal cancer with multiple lymph node metastases in his chest. Local hospitals in Indonesia could not perform surgery. He consulted multiple overseas hospitals, but the responses were uniformly discouraging: “We can try, but experience is limited, and the prognosis is unclear.”

Through an international medical referral agency, Umar was connected to Zhujiang Hospital of Southern Medical University in Guangzhou, where he met Dr. Qiao Guibin, Director of the Department of Thoracic Surgery. “Esophageal cancer is not an incurable disease,” Dr. Qiao told him. “With standardized treatment, over 80% of early-stage esophageal cancer patients have a chance of clinical cure.”

After three rounds of chemotherapy combined with immunotherapy, Umar successfully underwent minimally invasive surgery. He was discharged just one week later. Umar stayed in Guangzhou for another month for recovery. At his final follow-up, Dr. Qiao told him: “You’ve recovered very well. Go home in peace — we will continue to follow up until you are fully healed.”

Umar’s case is one of thousands. Zhujiang Hospital’s International Medical Center, established in 1985, has served over 200,000 international patients from more than 50 countries. In 2025 alone, the center received over 10,000 international patient visits from 40+ countries (source: Life Times, March 2026; Southern Medical University Hospital Management Office).

How myMedVia Can Help

Navigating China’s healthcare system as an international patient can be daunting. That’s where myMedVia comes in.

Fast · Affordable · Certain

We connect international patients with South China’s top hospitals — from the First Affiliated Hospital of Sun Yat-sen University in Guangzhou to the Boao Lecheng Pilot Zone in Hainan. Our services include:

• Fast-track Access (from $300): Priority appointment scheduling, medical record review, and hospital coordination

• Full Concierge (from $1,000): End-to-end support including visa assistance, airport pickup, accommodation, in-person interpretation, and follow-up care coordination

If you’ve been waiting a month or more for treatment in your home country, don’t wait any longer. South China’s world-class hospitals are ready to see you — often within days.

Contact myMedVia today for a free case evaluation.